TSWM
FLGT icon

Tyler-Stone Wealth Management’s Fulgent Genetics FLGT Stock Holding History

Tyler-Stone Wealth Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-13
Closed -$255 – 522
2024
Q2 		$255 Hold
13
– – ﹤0.01% 949
2024
Q1 		$282 Hold
13
– – ﹤0.01% 933
2023
Q4 		$376 Hold
13
– – ﹤0.01% 907
2023
Q3 		$0 Hold
13
– – ﹤0.01% 923
2023
Q2 		$0 Buy
+13
New +$453 ﹤0.01% 897
2022
Q4 		$0 Hold
13
– – ﹤0.01% 872
2022
Q3 		$0 Hold
13
– – ﹤0.01% 873
2022
Q2 		$1K Hold
13
– – ﹤0.01% 808
2022
Q1 		$1K Hold
13
– – ﹤0.01% 785
2021
Q4 		$1K Buy
+13
New +$1.14K ﹤0.01% 855

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Tyler-Stone Wealth Management's FLGT Position: Q3 2024 in Review

Tyler-Stone Wealth Management sold out of Fulgent Genetics (FLGT) in Q3 2024, closing a stake of 13 shares — an estimated $255 sold.

Tyler-Stone Wealth Management first reported a position in FLGT in Q4 2021 and held it in 10 quarters. The position peaked at $1K in Q2 2022. 183 funds tracked by Wall St. Rank hold FLGT as of Q3 2024.

  • Tyler-Stone Wealth Management reported no remaining Fulgent Genetics position as of Q3 2024 after selling out during the quarter.
  • Tyler-Stone Wealth Management sold 13 Fulgent Genetics shares in Q3 2024, an estimated $255.
  • Tyler-Stone Wealth Management first reported a position in Fulgent Genetics in Q4 2021 and held it in 10 quarters.
  • Tyler-Stone Wealth Management's Fulgent Genetics position peaked at $1K in Q2 2022.
  • 183 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2024.

Based on Tyler-Stone Wealth Management's 13F filing for Q3 2024, filed 4 Nov 2024.